0 of 6 Questions completed
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading…
You must sign in or sign up to start the quiz.
You must first complete the following:
0 of 6 Questions answered correctly
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
You must score 0% to continue. Please click the link below to re-take the quiz
1. What is your degree?
2. What is your specialty?
3. How confident are you in the management of patients with ES-SCLC in your practice?
4. Which of the following FDA-approved and guideline-recommended treatment regimens would you prescribe as second-line therapy for a 62-year-old male patient with disease recurrence 90 days after the 4th cycle of chemo/ICI therapy?
5. In what setting might chemo rechallenge be an appropriate treatment option for a patient with SCLC and disease relapse after completion of first-line chemotherapy?
6. In a patient with LS-SCLC whose disease has relapsed after completing chemo and while receiving topotecan for ES-SCLC, which PD-1/PD-L1 inhibitor would be the best treatment choice if the patient had tumoral PD-L1 expression ≥ 1% and had not received prior IO?